Latest Investments News

RMA Global Limited has rebranded RateMyAgent to Renowned, integrating Curated Social to enhance its real estate marketing platform. The company’s strategic pivot in the US is paying off with record brokerage deals and strong revenue growth.

Resmed Inc. posted robust Q2 FY2026 results, with revenue climbing 11% to $1.4 billion and a 16% rise in non-GAAP earnings per share, underpinned by strong global demand and operational efficiencies.

NewPeak Metals has commenced drilling at its Tansey Gold Project in Queensland while securing full ownership and environmental approvals for its Las Opeñas Gold Project in Argentina, setting the stage for expanded exploration in 2026.

AdAlta Limited has launched its 'East to West' cellular immunotherapy operations through a strategic collaboration with Shanghai Cell Therapy Group to co-develop BZDS1901, an innovative CAR-T therapy targeting mesothelioma and other solid cancers. The company also strengthened its balance sheet by raising $2.8 million via private placements and repaying key investment agreements.

Fluence Corporation Limited has reported a robust FY 2025 with a 52.3% revenue increase and record new orders, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams.

WhiteHawk Limited reported steady Q4 revenue and advanced multiple government and academic contracts in the US and Australia, underpinning its growth in cybersecurity services.

Titomic has made significant strides in transitioning from development to production, securing key contracts in defense and semiconductor sectors while maintaining a strong cash position.

Lake Resources NL reported a solid quarter ending December 2025, progressing regulatory approvals for its Kachi Lithium Brine Project while slashing cash outgoings by 45% year-on-year and maintaining strong liquidity amid a sharp lithium price rally.

Fluence Corporation Limited reported a positive net operating cash flow of US$3.824 million for the December 2025 quarter, ending with a strong cash position of US$16.64 million. The company’s disciplined spending and financing activities underpin its stable liquidity outlook.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

Pancontinental Energy has identified two new prospects in its PEL 87 permit, boosting its high case prospective resources to 6.1 billion barrels of oil net to the company. While progressing farmout discussions, the company awaits a critical permit extension decision from Namibian authorities.

xReality Group Limited has reported its strongest quarter yet, with record cash receipts and a doubling sales pipeline, underpinned by major US defence contracts and expanded production capacity.